Capital Expenditures - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.15 CNY -3.17% Market Closed
Market Cap: 3.8B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novogene Co Ltd
Capital Expenditures Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Capital Expenditures
-ÂĄ116.7m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Capital Expenditures
-ÂĄ4.6B
CAGR 3-Years
0%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Capital Expenditures
-ÂĄ2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Capital Expenditures
-ÂĄ4.2B
CAGR 3-Years
16%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Capital Expenditures
-ÂĄ359m
CAGR 3-Years
-8%
CAGR 5-Years
-31%
CAGR 10-Years
-25%
Genscript Biotech Corp
HKEX:1548
Capital Expenditures
-$177.1m
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Capital Expenditures?
Capital Expenditures
-116.7m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Capital Expenditures amounts to -116.7m CNY.

What is Novogene Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-8%

Over the last year, the Capital Expenditures growth was 46%. The average annual Capital Expenditures growth rates for Novogene Co Ltd have been -8% over the past three years , -8% over the past five years .

Back to Top